- €8.60bn
- €8.49bn
- €4.07bn
Europe Research Roundup: Believe, Deliveroo, Mondi
Brief: Biomerieux Sees 2024 Sales Growth Of Between +6% And +8%
Brief: Biomerieux Appoints Dr. Charles K. Cooper As Chief Medical Officer
EPS to determine 2024 winners and losers in European medtech -MS
Brief: Biomerieux Acquires LUMED
Europe Research Roundup: Argenx, Epiroc, Volkswagen
Brief: Biomerieux Confirmation Of The 2023 Guidance
France's bioMérieux to invest 70 mln stg in Oxford Nanopore
Brief: Biomerieux Makes Strategic Investment In Oxford Nanopore
Brief: Biomerieux Receives CE-Marking Of VIDAS TBI
HSBC prefers Biomerieux as healthcare equipment sector struggles with COVID unwind
Europe Research Roundup: Biomerieux, Eurofins Scientific, OCI NV
Brief: Biomerieux Submits Dual 510K And Clia-Waiver Application To FDA For Biofire Spotfire Panel
Europe Research Roundup: B&M, Colruyt, Sanofi
Biomerieux tracks worst day in almost a year after EBIT miss
Brief: Biomerieux H1 Operating Income Down At EUR 208 Million
Brief: Biomérieux Appoints Pierre Boulud As CEO
French and Benelux stocks-Factors to watch
Brief: BioMérieux Receives U.S. FDA CLIA-Waiver For BIOFIRE SPOTFIRE Respiratory (R) Panel Mini